Results in 2010, from a Phase III clinical trial of<unk>  showed that the drug can effectively reduce blood sugar.
Linagliptin
Liraglutide
Vildagliptin
Exenatide
Saxagliptin
Sitagliptin
Pioglitazone
Canagliflozin